Karen L. Fearon
University of Washington
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Karen L. Fearon.
Nature Biotechnology | 2000
Sydney Brenner; Maria Johnson; John Bridgham; George Golda; David H. Lloyd; Davida Johnson; Shujun Luo; Sarah N. McCurdy; Michael F. Foy; Mark Ewan; Rithy Roth; Dave George; Sam Eletr; Glenn Albrecht; Eric Vermaas; Steven R. Williams; Keith Moon; Timothy Burcham; Michael C. Pallas; Robert B. Dubridge; James J. Kirchner; Karen L. Fearon; Jen-I Mao; Kevin Corcoran
We describe a novel sequencing approach that combines non-gel-based signature sequencing with in vitro cloning of millions of templates on separate 5 μm diameter microbeads. After constructing a microbead library of DNA templates by in vitro cloning, we assembled a planar array of a million template-containing microbeads in a flow cell at a density greater than 3 × 106 microbeads/cm2. Sequences of the free ends of the cloned templates on each microbead were then simultaneously analyzed using a fluorescence-based signature sequencing method that does not require DNA fragment separation. Signature sequences of 16–20 bases were obtained by repeated cycles of enzymatic cleavage with a type IIs restriction endonuclease, adaptor ligation, and sequence interrogation by encoded hybridization probes. The approach was validated by sequencing over 269,000 signatures from two cDNA libraries constructed from a fully sequenced strain of Saccharomyces cerevisiae, and by measuring gene expression levels in the human cell line THP-1. The approach provides an unprecedented depth of analysis permitting application of powerful statistical techniques for discovery of functional relationships among genes, whether known or unknown beforehand, or whether expressed at high or very low levels.
Current protocols in human genetics | 2001
Karen L. Fearon; Jeffrey S. Nelson
This unit describes the synthesis and purification of oligonucleotide N3′→︀P5′ phosphoramidates, wherein each 3′‐oxygen is replaced by a 3′‐amine in the 2′‐deoxyribose ring. The synthesis of required monomers and application of the method to preparation of phosphodiester‐ and phosphorothioate‐containing chimera of phosphoramidate is also reported.
Journal of Medicinal Chemistry | 1987
Karen L. Fearon; Andreas Spaltenstein; Michael H. Gelb
Journal of Organic Chemistry | 1997
Jeffrey S. Nelson; Karen L. Fearon; Mark Q. Nguyen; Sarah N. McCurdy; Jeff E. Frediani; Michael F. Foy; Bernard L. Hirschbein
Journal of Organic Chemistry | 1989
Wei Yuan; Karen L. Fearon; Michael H. Gelb
Journal of Organic Chemistry | 1995
Andrzej Okruszek; Agnieszka Sierzchała; Karen L. Fearon; Wojciech J. Stec
Archive | 1996
Bernard L. Hirschbein; Karen L. Fearon; Sergei M. Gryaznov; Sarah N. McCurdy; Jeffery S. Nelson; Ronald G. Schultz
Nucleic Acids Research | 1998
Karen L. Fearon; Bernard L. Hirschbein; Jeffrey S. Nelson; Michael F. Foy; Mark Q. Nguyen; Sarah N. McCurdy; Jeff E. Frediani; Lawrence A. DeDionisio; Annette M. Raible; E. Neil Cagle; Andrzej Okruszek; Vicky Boyd
Archive | 1996
Bernard L. Hirschbein; Karen L. Fearon; Sergei M. Gryaznov; Sarah N. McCurdy; Jeffrey S. Nelson; Ronald G. Schultz
Antisense & Nucleic Acid Drug Development | 1999
Patricia Hawley; Jeffrey S. Nelson; Karen L. Fearon; Gerald Zon; Ian Gibson